Shelly Elese Sakiyama-Elbert

Shelly Elese Sakiyama-Elbert

Auto-generated profile, based on publicly available information

Shelly Elese Sakiyama-Elbert

Department of Bioengineering, University of Washington, Seattle, WA 98195, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2007 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
Stephanie WillerthStephanie Willerth
Stephanie Willerth
SSShelly E. Sakiyama-Elbert
Shelly E. Sakiyama-Elbert

1 December 2006 in Biomaterials
Verified
Journal Article
Open access
Stephanie WillerthStephanie Willerth
Stephanie Willerth
KAKelly J. Arendas
Kelly J. Arendas
DGDavid I. Gottlieb
David I. Gottlieb
SSShelly Elese Sakiyama-Elbert
Shelly Elese Sakiyama-Elbert
The objective of this research was to determine the appropriate cell culture conditions for embryonic stem (ES) cell proliferation and differentiation in fibrin scaffolds by examining cell seeding density, location, and the optimal concentrations of fibrinogen, thrombin, and aprotinin (protease inhibitor). Mouse ES cells were induced to become neural progenitors by adding retinoic acid for 4 days to embryoid body (EB) cultures. For dissociated EBs, the optimal cell seeding density and location was determined to be 250,000 cells/cm(2) seeded on top of fibrin scaffolds. For intact EBs, three-dimensional (3D) cultures with one EB per 400 microL fibrin scaffold resulted in greater cell proliferation and differentiation than two-dimensional (2D) cultures. Optimal concentrations for scaffold polymerization were 10mg/mL of fibrinogen and 2 NIH units/mL of thrombin. The optimal aprotinin concentration was determined to be 50 microg/mL for dissociated EBs (2D) and 5 microg/mL for intact EBs in 3D fibrin scaffolds. Additionally, after 14 days in 3D culture EBs differentiated into neurons and astrocytes as indicated by immunohistochemisty. These conditions provide an optimal fibrin scaffold for evaluating ES cell differentiation and proliferation in culture, and for use as a platform for neural tissue engineering applications, such as the treatment for spinal cord injury.

1 April 2014 in Acta Biomaterialia
Verified
Journal Article
Closed access
SSShelly E. Sakiyama-Elbert
Shelly E. Sakiyama-Elbert

1 January 2010 in Cell Transplantation
Verified
Journal Article
Open access
PJPhilip J. Johnson
Philip J. Johnson
ATAlexander Tatara
Alexander Tatara
ASAlicia Shiu
Alicia Shiu
SSShelly E. Sakiyama-Elbert
Shelly E. Sakiyama-Elbert
A consistent problem with stem/neural progenitor cell transplantation following spinal cord injury (SCI) is poor cell survival and uncontrolled differentiation following transplantation. The current study evaluated the feasibility of enhancing embryonic stem cell-derived neural progenitor cell (ESNPC) viability and directing their differentiation into neurons and oligodendrocytes by embedding the ESNPCs in fibrin scaffolds containing growth factors (GF) and a heparin-binding delivery system (HBDS) in a subacute rat model of SCI. Mouse ESNPCs were generated from mouse embryonic stem cells (ESCs) using a 4–/4+ retinoic acid (RA) induction protocol. The ESNPCs were then transplanted as embryoid bodies (EBs, 70% neural progenitor cells) into the subacute model of SCI. ESNPCs (10 EBs per animal) were implanted directly into the SCI lesion, encapsulated in fibrin scaffolds, encapsulated in fibrin scaffolds containing the HBDS, neurotrophin-3 (NT-3), and platelet-derived growth factor (PDGF), or encapsulated in fibrin scaffolds with NT-3 and PDGF with no HBDS. We report here that the combination of the NT-3, PDGF, and fibrin scaffold (with or without HBDS) enhanced the total number of ESNPCs present in the spinal cord lesion 2 weeks after injury. In addition, the inclusion of the HBDS with growth factor resulted in an increase in the number of ESNPC-derived NeuN-positive neurons. These results demonstrate the ability of fibrin scaffolds and the controlled release of growth factors to enhance the survival and differentiation of neural progenitor cells following transplantation into a SCI model.

16 April 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
CMCionne N Manning
Cionne N Manning
CMCatherine Martel
Catherine Martel
SSShelly E Sakiyama-Elbert
Shelly E Sakiyama-Elbert
MSMatthew J Silva
Matthew J Silva
SSShivam Shah
Shivam Shah
STStavros Thomopoulos
Stavros Thomopoulos
Introduction: Macrophage-driven inflammation is a key feature of the early period following tendon repair, but excessive inflammation has been associated with poor clinical outcomes. Modulation of the inflammatory environment using molecular or cellular treatments may provide a means to enhance tendon healing. Methods: To examine the effect of pro-inflammatory cytokines secreted by macrophages on tendon fibroblasts (TF), we established in vitro models of cytokine and macrophage-induced inflammation. Gene expression, protein expression, and cell viability assays were used to examine TF responses. In an effort to reduce the negative effects of inflammatory cytokines on TFs, adipose-derived mesenchymal stromal cells (ASCs) were incorporated into the model and their ability to modulate inflammation was investigated. Results: The inflammatory cytokine interleukin 1 beta (IL-1β) and macrophages of varying phenotypes induced up-regulation of pro-inflammatory factors and matrix degradation factors and down-regulation of factors related to extracellular matrix formation by TFs in culture. ASCs did not suppress these presumably negative effects induced by IL-1β. However, ASC co-culture with M1 (pro-inflammatory) macrophages successfully suppressed the effects of M1 macrophages on TFs by inducing a phenotypic switch from a pro-inflammatory macrophage phenotype to an anti-inflammatory macrophage phenotype, thus resulting in exposure of TFs to lower levels of pro-inflammatory cytokines (e.g., IL-1β, tumor necrosis factor alpha (TNFα)). Conclusions: These findings suggest that IL-1β and M1 macrophages are detrimental to tendon healing and that ASC-mediated modulation of the post-operative inflammatory response may be beneficial for tendon healing.

1 May 2009 in Acta Biomaterialia
Verified
Journal Article
Closed access
MWMatthew Wood
Matthew Wood
AMAmy M. Moore
Amy M. Moore
DHDaniel A. Hunter
Daniel A. Hunter
STSami Tuffaha
Sami Tuffaha
GBGregory H Borschel
Gregory H Borschel
SSShelly E. Sakiyama-Elbert
Shelly E. Sakiyama-Elbert